| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFESSIONAL FEES | 1,500 | 1,500 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 5000 SHARES EYEGATE PHARM | 2015-02 | PURCHASE | 2015-02 | 30,335 | 30,000 | 335 | ||||
| 54800 SHARES STEMCELLS INC | 2015-04 | PURCHASE | 2015-05 | 35,756 | 38,360 | -2,604 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENTS | 300,346 | 178,721 |
| OTHER INVESTMENT | 125,000 | 125,000 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| UNREALIZED CURRENCY LOSS | 2,202 | 5,318 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFESSIONAL LICENSES | 100 | 100 | ||
| FEDERAL EXCISE TAX | 149 | 149 |